Skip to content
patentreply.ai
Office Action responsePricingSecurityDocs

US 9,573,992 · Application 14/128,719

US Patent 9,573,992 — assignment history and current owner

Serum Albumin Binding Proteins

Who owns US Patent 9,573,992?

US9573992 ("Serum Albumin Binding Proteins") — current assignee: SANOFI. Status: Active, estimated expiration September 30, 2031. 2 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 9,573,992 is SANOFI. Based on the most recent ownership transfer record (recorded 2022-05-10).

Patent title
Serum Albumin Binding Proteins
Application number
14/128,719
Apparent operating assignee
SANOFI
Patent status
Active, estimated expiration September 30, 2031
Recorded assignments
2

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Mar 10, 2014Mar 19, 2014Ownership TransferDOMBRECHT, BRUNO; VERVERKEN, CEDRIC JOZEF NEOTERE; SCHOTTE, PETERABLYNX N.V.32474/892
May 2, 2022May 10, 2022Ownership TransferABLYNX N.V.SANOFI59883/339

Scrolls sideways on narrow screens

Chain of title

In 2014, DOMBRECHT, BRUNO; VERVERKEN, CEDRIC JOZEF NEOTERE (+1 more) assigned the patent to ABLYNX N.V.. The most recent ownership transfer, recorded in 2022, lists SANOFI as assignee.

When does this patent expire?Look up another patent

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

The prosecution record for your AI

Application 14/128,719 · US 9,573,992

Ownership settled? Give your AI the file.

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 9,573,992, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.

One new public application a month is free. The first compile takes a few minutes.

Connect PatentReplySee the evidence

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.

patentreply.ai
How it worksOffice Action responsePricingDocsConnectToolsSecurityPrivacyTermsContact

© 2026 patentreply.ai

PatentReply does not train on your matters. PatentReply is not a law firm and does not practice law; it requires attorney involvement where legal judgment belongs, and you remain the practitioner of record.